Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993

Journal of the American Society of Nephrology

Volumn 9, Issue 11, 1998, Pages 2108-2117

  Collins, Allan J ^a,b   Ma, Jennie Z ^a   Constantini, Edward G ^a   Everson, Susan E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FORMALDEHYDE; GLUTARALDEHYDE; PERACETIC ACID;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PRIORITY JOURNAL; PROFIT; REGRESSION ANALYSIS; RISK FACTOR; SAFETY; UNITED STATES;

EID: 0031787450     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Shaldon S, Silva H, Rosen S: Technique of refrigerated coil preservation hemodialysis with femoral venous catheterization. Br Med J 2: 411-413, 1964
2. Tokars J, Alter M, Favero M, Moyer L, Bland L: National surveillance of hemodialysis-associated diseases in the United States, 1990. ASAIO J 39: 71-80, 1993
3. Association for the Advancement of Medical Instrumentation: Recommended Practice for Reuse of Hemodialyzers, Arlington, VA, 1986
4. Diaz R, Washburn S, Cauble L, Siskind M, Van Wyck D: The effect of dialyzer reprocessing on performance and beta 2-microglobulin removal using polysulfone membranes. Am J Kidney Dis 21: 405-410, 1993
5. Windus D, Atkinson R, Santoro S: The effect of hemodialysis on platelet activation with new and reprocessed regenerated cellulose dialyzers. Am J Kidney Dis 27: 387-393, 1996
6. Kerr P, Argiles A, Canaud B, Flavier J, Mion C: The effects of reprocessing high-flux polysulfone dialyzers with peroxyacetic acid on beta 2-microglobulin removal in hemodiafiltration. Am J Kidney Dis 19: 433-438, 1992
7. Pereira B, King A, Poutsiaka D, Strom J, Dinarello C: Comparison of first use and reuse of Cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells. Am J Kidney Dis 22: 288-295, 1993
8. Kaplan A, Halley S, Lapkin R, Graeber C: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 47: 573-578, 1995
9. Jackson B, Beck-Sague C, Bland L, Arduino M, Meyer L, Jarvis W: Outbreak of pyrogenic reactions and Gram-negative bacteremia in a hemodialysis center. Am J Nephrol 14: 85-89, 1994
10. Vanholder R, Vanhaecke E, Ringoir S: Pseudomonas septicemia due to deficient disinfectant mixing during reuse. Int J Artif Organs 15: 19-24, 1992
11. Pegues D, Beck-Sague C, Woollen S, Greenspan B, Burns S, Bland L, Arduino M, Favero M, Machow R, Jarvis W: Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 42: 1232-1237, 1992
12. Pegues D, Oettinger C, Bland L, Oliver J, Arduino M, Aguero S, McAllister S, Gordon S, Favero M, Jarvis W: A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 3: 1002-1007, 1992
13. Cheung A, Dalpias D, Emmerson R, Leypoldt J: A prospective study on intradialytic symptoms associated with reuse of hemodialyzers. Am J Nephrol 11: 397-401, 1991
14. Tokars J, Alter M, Favero M, Moyer L, Bland L: National surveillance of hemodialysis-associated diseases in the United States, 1990. ASAIO J 39: 71-80, 1993
15. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of dialysis associated diseases in the United States, 1991. ASAIO J 39: 966-975, 1993
16. Alter M, Favero M, Moyer L, Miller J, Bland L: National surveillance of dialysis-associated diseases in the United States, 1988. ASAIO Trans 36: 107-118, 1990
17. Alter M, Favero M, Moyer L, Bland L: National surveillance of dialysis-associated diseases in the United States, 1989. ASAIO Trans 37: 97-109, 1991
18. Held PJ, Wolfe RA, Gaylin DS, Port FK, Levin NW, Turenne MN: Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 23: 692-708, 1994
19. Luehmann D, Cosentino L: Safety of dialyzer reuse with Renalin: The untold story. Dial Transplant 23: 248-258, 1994
20. Feldman H, Kinosian M, Bilker W, Simmons C, Holmes J, Pauly M, Escarce J: Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA 276: 620-625, 1996
21. Social Security Administration: Social Security: Your Number [Pamphlet]. 4: 1996
22. Health Care Financing Administration: Data Users Reference Guide [Catalog]. Baltimore, Health Care Financing Administration, 1995
23. US Renal Data System: USRDS 1996 Annual Data Report, Bethesda, 1996
24. Keane W, Collins A: Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 24: 1010-1018, 1994
25. Shapiro F, Umen A: Risk factors in hemodialysis patient survival. ASAIO J 6: 176-184, 1983
26. Gaylin DS, Held PJ, Port FK, Hunsicker LG, Wolfe RA, Kahan BD, Jones CA, Agodoa LY: The impact of comorbid and socio-demographic factors on access to renal transplantation. JAMA 269: 603-608, 1993
27. Held PJ, Port FK, Gaylin DS, Wolfe RA, Levin NW, Blagg CR, Garcia JR, Agodoa LY: Evaluations of initial predictors of mortality among new ESRD patients: The USRDS Case Mix Study [Abstract]. J Am Soc Nephrol 2: 328, 1991
28. Cox D: Regression models and life-tables. J Roy Stat Soc Series B 34: 187-220, 1972
29. Brookmeyer R, Gail MH: Biases in prevalent cohorts. Biometrics 43: 739-749, 1987
30. U.S. Renal Data System: USRDS 1997 Annual Data Report, Bethesda, 1997
31. Collins A, Ma J, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 23: 272-282, 1994
32. Madore F, Lowrie E, Brugnara C, Lew N, Lazarus M, Bridges K, Owen K: Anemia in hemodialysis patients: Variables affecting this outcome predictor. J Am Soc Nephrol 8: 1921-1929, 1997